Complex diseases demand novel treatment strategies: understanding drug combination (2022)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; MELLO, RENATA SIQUEIRA DE - IQ ; SAMPAIO, VANESSA FERNANDES ARNAUD - IQ ; GLASER, TALITA - IQ
- Unidade: IQ
- DOI: 10.53388/DCT2022006
- Subjects: MEDICAMENTO; TERAPIA COMBINADA
- Language: Inglês
- Imprenta:
- Source:
- Título: Drug Combination Therapy
- ISSN: 2624-3075
- Volume/Número/Paginação/Ano: v. 4, n. 2, p. 1-12 art. 6, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
MELLO, Renata Siqueira de et al. Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, v. 4, n. 2, p. 1-12 art. 6, 2022Tradução . . Disponível em: https://doi.org/10.53388/DCT2022006. Acesso em: 03 nov. 2024. -
APA
Mello, R. S. de, Sampaio, V. F. A., Maciel, L. F., Sá, V. de, Glaser, T., Ulrich, H., & Lameu, C. (2022). Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, 4( 2), 1-12 art. 6. doi:10.53388/DCT2022006 -
NLM
Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 nov. 03 ] Available from: https://doi.org/10.53388/DCT2022006 -
Vancouver
Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 nov. 03 ] Available from: https://doi.org/10.53388/DCT2022006 - P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
- Calcium signalling: a common target in neurological disorders and neurogenesis
- Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
- Purinergic receptors in neurogenic processes
- Purinergic signaling: an overview
- Huntingtin protein maintains balanced energetics in mouse cardiomyocytes
- Purinergic signaling in brain physiology
- Therapeutic effects of cannabinoids and their applications in COVID-19 treatment
- P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway
- Adenosinergic-dopaminergic signaling in mood disorders: a mini-review
Informações sobre o DOI: 10.53388/DCT2022006 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 3084077.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
